Terms: = Head and neck cancer AND VHL, HRCA1, P40337, 7428, ENSG00000134086, RCA1, VHL1 AND Treatment
45 results:
1. Analysis of Factors Contributing to Adverse Events and Evaluation of Their Impact on Prognosis in Metastatic Renal Cell Carcinoma Patients-Real-World Experience in a Single-Center Retrospective Study and Narrative Review.
Domański P; Piętak M; Staneta S; Fortuniak W; Kruczyk B; Kobiernik A; Bakuła P; Mydlak A; Demkow T; Sikora-Kupis B; Dumnicka P; Kucharz J
Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541124
[No Abstract] [Full Text] [Related]
2. Tumor hypoxia and role of hypoxia-inducible factor in oral cancer.
Singh P; Rajput M; Pandey M
World J Surg Oncol; 2024 Jan; 22(1):18. PubMed ID: 38200568
[TBL] [Abstract] [Full Text] [Related]
3. Consensus Guidelines for Ocular Surveillance of von Hippel-Lindau Disease.
Daniels AB; Chang EY; Chew EY; Gombos DS; Gorin MB; Shields CL; Wiley HE
Ophthalmology; 2024 May; 131(5):622-633. PubMed ID: 38092079
[TBL] [Abstract] [Full Text] [Related]
4. Personalized Systemic Therapies in Hereditary cancer Syndromes.
Mastrodomenico L; Piombino C; Riccò B; Barbieri E; Venturelli M; Piacentini F; Dominici M; Cortesi L; Toss A
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980956
[TBL] [Abstract] [Full Text] [Related]
5. LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing vhl through a non-canonical function of EZH2.
Duan Y; Yue K; Ye B; Chen P; Zhang J; He Q; Wu Y; Lai Q; Li H; Wu Y; Jing C; Wang X
Cell Death Dis; 2023 Feb; 14(2):149. PubMed ID: 36813772
[TBL] [Abstract] [Full Text] [Related]
6. vhl tumor suppressor as a novel potential candidate biomarker in papillary thyroid carcinoma.
Todorović L; Stanojević B
Biomol Biomed; 2023 Feb; 23(1):26-36. PubMed ID: 36036061
[TBL] [Abstract] [Full Text] [Related]
7. Downregulation of lncRNA APCDD1L-AS1 due to DNA hypermethylation and loss of vhl protein expression promotes the progression of clear cell renal cell carcinoma.
Yang W; Zhou J; Zhang Z; Zhang K; Xu Y; Li L; Cai L; Gong Y; Gong K
Int J Biol Sci; 2022; 18(6):2583-2596. PubMed ID: 35414787
[No Abstract] [Full Text] [Related]
8. Clinicopathological and Molecular Features of Secondary cancer (Metastasis) to the Thyroid and Advances in Management.
Nguyen M; He G; Lam AK
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328664
[TBL] [Abstract] [Full Text] [Related]
9. [Endocrine and neuroendocrine tumors].
Riss P; Scheuba K; Strobel O
Chirurg; 2021 Nov; 92(11):996-1002. PubMed ID: 34618164
[TBL] [Abstract] [Full Text] [Related]
10. Endolymphatic sac tumor: single-institution series of seven cases with updated review of literature.
Talukdar R; Epari S; Sahay A; Choudhari A; Dasgupta A; Chatterjee A; Gupta T
Eur Arch Otorhinolaryngol; 2022 May; 279(5):2591-2598. PubMed ID: 34410472
[TBL] [Abstract] [Full Text] [Related]
11. The Association of the BRAF-V600E Mutation with the Expression of the Molecular Markers in the Primary Tumor and Metastatic Tissue in Papillary Thyroid cancer.
Spirina LV; Chizhevskaya SY; Kovaleva IV; Kondakova IV
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2017-2024. PubMed ID: 34319022
[TBL] [Abstract] [Full Text] [Related]
12. head and neck paragangliomas in Norway, importance of genetics, updated diagnostic workup and treatment.
Rana MU; Østhus AA; Heimdal K; Jebsen P; Revheim MR; Osnes TA
Acta Otolaryngol; 2021 Mar; 141(3):303-308. PubMed ID: 33320715
[TBL] [Abstract] [Full Text] [Related]
13. ASC modulates HIF-1α stability and induces cell mobility in OSCC.
Wu CS; Chang IY; Hung JL; Liao WC; Lai YR; Chang KP; Li HP; Chang YS
Cell Death Dis; 2020 Sep; 11(9):721. PubMed ID: 32883954
[TBL] [Abstract] [Full Text] [Related]
14. Long experience for the diagnosis and treatment of sporadic endolymphatic sac tumor in a single center.
Guo F; Zhang L; Mo L
Clin Neurol Neurosurg; 2020 Oct; 197():106078. PubMed ID: 32673897
[TBL] [Abstract] [Full Text] [Related]
15. Screening guidelines and recommendations for patients at high risk of developing endocrine cancers.
Geurts JL; Strong EA; Wang TS; Evans DB; Clarke CN
J Surg Oncol; 2020 May; 121(6):975-983. PubMed ID: 32090344
[TBL] [Abstract] [Full Text] [Related]
16. What determines mortality in malignant pheochromocytoma? - Report of a case with eighteen-year survival and review of the literature.
Andrade MO; Cunha VSD; Oliveira DC; Moraes OL; Lofrano-Porto A
Arch Endocrinol Metab; 2018; 62(2):264-269. PubMed ID: 29768630
[TBL] [Abstract] [Full Text] [Related]
17. Review of the Neurological Implications of von Hippel-Lindau Disease.
Dornbos D; Kim HJ; Butman JA; Lonser RR
JAMA Neurol; 2018 May; 75(5):620-627. PubMed ID: 29379961
[TBL] [Abstract] [Full Text] [Related]
18. PHEOCHROMOCYTOMA: A GENETIC and DIAGNOSTIC UPDATE.
Mercado-Asis LB; Wolf KI; Jochmanova I; Taïeb D
Endocr Pract; 2018 Jan; 24(1):78-90. PubMed ID: 29144820
[TBL] [Abstract] [Full Text] [Related]
19. Suppression of the Growth and Invasion of Human head and neck Squamous Cell Carcinomas via Regulating STAT3 Signaling and the miR-21/β-catenin Axis with HJC0152.
Wang Y; Wang S; Wu Y; Ren Y; Li Z; Yao X; Zhang C; Ye N; Jing C; Dong J; Zhang K; Sun S; Zhao M; Guo W; Qu X; Qiao Y; Chen H; Kong L; Jin R; Wang X; Zhang L; Zhou J; Shen Q; Zhou X
Mol Cancer Ther; 2017 Apr; 16(4):578-590. PubMed ID: 28138036
[TBL] [Abstract] [Full Text] [Related]
20. Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors.
Babic B; Patel D; Aufforth R; Assadipour Y; Sadowski SM; Quezado M; Nilubol N; Prodanov T; Pacak K; Kebebew E
Surgery; 2017 Jan; 161(1):220-227. PubMed ID: 27865588
[TBL] [Abstract] [Full Text] [Related]
[Next]
